Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rho GTPases: Anti- or pro-neoplastic targets?
Zandvakili I, Lin Y, Morris JC, Zheng Y. Zandvakili I, et al. Oncogene. 2017 Jun 8;36(23):3213-3222. doi: 10.1038/onc.2016.473. Epub 2016 Dec 19. Oncogene. 2017. PMID: 27991930 Free PMC article. Review.
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.
Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, Zandvakili I, Shakeri R, Sotoudeh M, Aghcheli K, Salahi R, Pourshams A, Semnani S, Boffetta P, Dawsey SM, Ghadirian P, Narod SA. Akbari MR, et al. Among authors: zandvakili i. Oncogene. 2008 Feb 21;27(9):1290-6. doi: 10.1038/sj.onc.1210739. Epub 2007 Aug 27. Oncogene. 2008. PMID: 17724471
Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA. Akbari MR, et al. Among authors: zandvakili i. Breast Cancer Res Treat. 2009 Jan;113(2):377-81. doi: 10.1007/s10549-008-9938-z. Epub 2008 Feb 28. Breast Cancer Res Treat. 2009. PMID: 18306035
Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
Calderon G, McRae A, Rievaj J, Davis J, Zandvakili I, Linker-Nord S, Burton D, Roberts G, Reimann F, Gedulin B, Vella A, LaRusso NF, Camilleri M, Gribble FM, Acosta A. Calderon G, et al. Among authors: zandvakili i. EBioMedicine. 2020 May;55:102759. doi: 10.1016/j.ebiom.2020.102759. Epub 2020 Apr 25. EBioMedicine. 2020. PMID: 32344198 Free PMC article. Clinical Trial.